Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology: Neuroimmunology & Neuroinflammation COVID-19 Article Hub
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology: Neuroimmunology & Neuroinflammation COVID-19 Article Hub
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit Manuscript
    • Author Center
  • Home
  • Articles
  • Issues
  • COVID-19 Article Hub
  • Infographics & Video Summaries

User menu

  • My Alerts
  • Log in

Search

  • Advanced search
Neurology Neuroimmunology & Neuroinflammation
Home
A peer-reviewed clinical and translational neurology open access journal
  • My Alerts
  • Log in
Site Logo
  • Home
  • Articles
  • Issues
  • COVID-19 Article Hub
  • Infographics & Video Summaries

Share

November 2019; 6 (6)

Share

Editor's Corner

  • Open Access
    Learning from adverse treatment effects
    Josep Dalmau
    • Full Text
    • Full Text (PDF)

Editorial

  • Open Access
    Untangling normal aging from disease-related brain atrophy in MS
    Tim Sinnecker, Jens Wuerfel
    • Full Text
    • Full Text (PDF)
  • Open Access
    Pembrolizumab as a treatment for PML?Waiting for Godot
    Renaud A. Du Pasquier
    • Full Text
    • Full Text (PDF)

Articles

  • Open Access
    Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors
    Alberto Vogrig, Marine Fouret, Bastien Joubert, Géraldine Picard, Véronique Rogemond, Anne-Laurie Pinto, Sergio Muñiz‐Castrillo, Maxime Roger, Judith Raimbourg, Charles Dayen, Laurianne Grignou, Maud Pallix-Guyot, Julien Lannoy, François Ducray, Virginie Desestret, Dimitri Psimaras, Jérôme Honnorat
    • Abstract
    • Full Text
    • Full Text (PDF)
  • Open Access
    HLA and microtubule-associated protein tau H1 haplotype associations in anti-IgLON5 disease
    Carles Gaig, Guadalupe Ercilla, Xavier Daura, Mario Ezquerra, Ruben Fernández-Santiago, Eduard Palou, Lidia Sabater, Romana Höftberger, Anna Heidbreder, Birgit Högl, Alex Iranzo, Joan Santamaria, Josep Dalmau, Francesc Graus
    • Abstract
    • Full Text
    • Full Text (PDF)
  • Open Access
    Late-onset neuromyelitis optica spectrum disorderThe importance of autoantibody serostatus
    Maria Sepulveda, Guillermo Delgado-García, Yolanda Blanco, Nuria Sola-Valls, Elena H. Martinez-Lapiscina, Thaís Armangué, Carmen Montejo, Irene Pulido-Valdeolivas, Eugenia Martinez-Hernandez, Helena Ariño, Domingo Escudero, Raquel Ruiz-García, Sara Llufriu, Josep Dalmau, Francesc Graus, Albert Saiz
    • Abstract
    • Full Text
    • Full Text (PDF)
  • Open Access
    Glutamine antagonism attenuates physical and cognitive deficits in a model of MS
    Kristen R. Hollinger, Matthew D. Smith, Leslie A. Kirby, Eva Prchalova, Jesse Alt, Rana Rais, Peter A. Calabresi, Barbara S. Slusher
    • Abstract
    • Full Text
    • Full Text (PDF)
  • Open Access
    Neurochondrin neurological autoimmunity
    Shahar Shelly, Thomas J. Kryzer, Lars Komorowski, Ramona Miske, Mark D. Anderson, Eoin P. Flanagan, Shannon R. Hinson, Vanda A. Lennon, Sean J. Pittock, Andrew McKeon
    • Abstract
    • Full Text
    • Full Text (PDF)
  • Open Access
    Lymphocyte counts and infection ratesLong-term fingolimod treatment in primary progressive MS
    Edward J. Fox, Fred D. Lublin, Jerry S. Wolinsky, Jeffrey A. Cohen, Ian M. Williams, Xiangyi Meng, Marina Ziehn, Scott Kolodny, Bruce A.C. Cree
    • Abstract
    • Full Text
    • Full Text (PDF)
  • Open Access
    Peripheral neuropathy in antineutrophil cytoplasmic antibody-associated vasculitidesInsights from the DCVAS study
    Antje Bischof, Veronika K. Jaeger, Robert D. M. Hadden, Raashid A. Luqmani, Anne-Katrin Pröbstel, Peter A. Merkel, Ravi Suppiah, Anthea Craven, Michael P. Collins, Thomas Daikeler
    • Abstract
    • Full Text
    • Full Text (PDF)
  • Open Access
    Contribution of normal aging to brain atrophy in MS
    Christina J. Azevedo, Steven Y. Cen, Amir Jaberzadeh, Ling Zheng, Stephen L. Hauser, Daniel Pelletier
    • Abstract
    • Full Text
    • Full Text (PDF)
  • Open Access
    Progressive multifocal leukoencephalopathyA 25-year retrospective cohort study
    Pria Anand, Gladia C. Hotan, Andre Vogel, Nagagopal Venna, Farrah J. Mateen
    • Abstract
    • Full Text
    • Full Text (PDF)
  • Open Access
    Effects of natalizumab therapy on intrathecal antiviral antibody responses in MS
    Fabienne Largey, Ivan Jelcic, Mireia Sospedra, Christoph Heesen, Roland Martin, Ilijas Jelcic
    • Abstract
    • Full Text
    • Full Text (PDF)
  • Open Access
    Vitamin D enhances responses to interferon-β in MS
    Xuan Feng, Zhe Wang, Quentin Howlett-Prieto, Nathan Einhorn, Suad Causevic, Anthony T. Reder
    • Abstract
    • Full Text
    • Full Text (PDF)
  • Open Access
    Elevated levels of miR-181c and miR-633 in the CSF of patients with MSA validation study
    Svenja Kramer, Arash Haghikia, Claudia Bang, Kristian Scherf, Angelika Pfanne, Alexander Duscha, Johannes Kaisler, Barbara Gisevius, Ralf Gold, Thomas Thum, Aiden Haghikia
    • Abstract
    • Full Text
    • Full Text (PDF)
  • Open Access
    Identification of circulating MOG-specific B cells in patients with MOG antibodies
    Stephan Winklmeier, Miriam Schlüter, Melania Spadaro, Franziska S. Thaler, Atay Vural, Ramona Gerhards, Caterina Macrini, Simone Mader, Aslı Kurne, Berin Inan, Rana Karabudak, Feyza Gül Özbay, Gunes Esendagli, Reinhard Hohlfeld, Tania Kümpfel, Edgar Meinl
    • Abstract
    • Full Text
    • Full Text (PDF)
  • Open Access
    Classifying the antibody-negative NMO syndromesClinical, imaging, and metabolomic modeling
    Tianrong Yeo, Fay Probert, Maciej Jurynczyk, Megan Sealey, Ana Cavey, Timothy D.W. Claridge, Mark Woodhall, Patrick Waters, Maria Isabel Leite, Daniel C. Anthony, Jacqueline Palace
    • Abstract
    • Full Text
    • Full Text (PDF)
  • Open Access
    IL6 receptor358Ala variant and trans-signaling are disease modifiers in amyotrophic lateral sclerosis
    Marlena Wosiski-Kuhn, Mac Robinson, Jane Strupe, Phonepasong Arounleut, Matthew Martin, James Caress, Michael Cartwright, Robert Bowser, Merit Cudkowicz, Carl Langefeld, Gregory A. Hawkins, Carol Milligan
    • Abstract
    • Full Text
    • Full Text (PDF)
  • Open Access
    Normal gut microbiome in NMDA receptor encephalitis
    Julia Herken, Corinna Bang, Malte C. Rühlemann, Carsten Finke, Johanna Klag, Andre Franke, Harald Prüss
    • Abstract
    • Full Text
    • Full Text (PDF)

Clinical/Scientific Notes

  • Open Access
    Steroid-sparing agents for the treatment of inflammation in complicated neurocysticercosis
    Pria Anand, Shibani S. Mukerji, Jesse Thon, Shauna Gunaratne, Tracey A. Cho, Nagagopal Venna
    • Full Text
    • Full Text (PDF)
  • Open Access
    CNS-disseminated Angiostrongylus cantonensis mimicking atypical demyelinating disease
    Daniel Long, Kemar Green, Talal Derani, Nicholas Decker, Robert J. Pace, Rany Aburashed
    • Full Text
    • Full Text (PDF)
  • Open Access
    Toll-like receptor 3 deficiency in autoimmune encephalitis post–herpes simplex encephalitis
    Thaís Armangue, Benjamin J. Baucells, Alexandru Vlagea, Mar Petit-Pedrol, Ana Esteve-Solé, Angela Deyà-Martínez, Raquel Ruiz-García, Manel Juan, Rebeca Pérez de Diego, Josep Dalmau, Laia Alsina
    • Full Text
    • Full Text (PDF)
  • Open Access
    CSF orexin-A levels after rituximab treatment in recent onset narcolepsy type 1
    Pontus Wasling, Clas Malmeström, Kaj Blennow
    • Full Text
    • Full Text (PDF)
  • Open Access
    Expanding the MOG phenotypeBrainstem encephalitis with punctate and curvilinear enhancement
    Susan Matesanz, Chelsea Kotch, Christopher Perrone, Angela J. Waanders, Brook Hill, Sona Narula
    • Full Text
    • Full Text (PDF)
  • Open Access
    Overnight loss of pigmented hair in autoimmune autonomic neuropathy treated with IVIg
    Lindsey E. Turner, Sean J. Pittock, Marian T. McEvoy, Eoin P. Flanagan
    • Full Text
    • Full Text (PDF)
  • Open Access
    Fatal PCR-negative herpes simplex virus-1 encephalitis with GABAA receptor antibodies
    Simon Schuster, Ligia Abrante, Jakob Matschke, Marc Lütgehetmann, Brigitte Holst, Mathias Gelderblom, Hanna Braass, Frank Leypoldt, Tim Magnus
    • Full Text
    • Full Text (PDF)
  • Open Access
    Ineffective treatment of PML with pembrolizumabExhausted memory T-cell subsets as a clue?
    Marc Pawlitzki, Tilman Schneider-Hohendorf, Leoni Rolfes, Sven G. Meuth, Heinz Wiendl, Nicholas Schwab, Oliver M. Grauer
    • Full Text
    • Full Text (PDF)
  • Open Access
    Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiency
    Clemens Küpper, Johanna Heinrich, Katharina Kamm, Veit Bücklein, Simon Rothenfusser, Andreas Straube
    • Full Text
    • Full Text (PDF)

Views & Reviews

  • Open Access
    Generation of neuroinflammation in human African trypanosomiasis
    Jean Rodgers, Israel Steiner, Peter G. E Kennedy
    • Abstract
    • Full Text
    • Full Text (PDF)
Back to top
PreviousNext
Previous IssueNext Issue
Neurology - Neuroimmunology Neuroinflammation: 6 (6)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Full Issue PDF
Subscribe to e-Alerts
RSS
Advertisement
Popular on
Neurology: Neuroimmunology & Neuroinflammation
  • Most Read
  • Most Cited
Loading
  • SARS-CoV-2–Specific Immune Responses in Patients With Postviral Syndrome After Suspected COVID-19
  • Peripheral Neuropathy Evaluations of Patients With Prolonged Long COVID
  • Mimics of Autoimmune EncephalitisValidation of the 2016 Clinical Autoimmune Encephalitis Criteria
  • Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient
  • NeurosarcoidosisPathophysiology, Diagnosis, and Treatment
More...

Association Between Fluctuations in Blood Lipid Levels Over Time With Incident Alzheimer Disease and Alzheimer Disease–Related Dementias

Dr. Sevil Yaşar and Dr. Behnam Sabayan

► Watch

Advertisement
Neurology - Neuroimmunology Neuroinflammation: 10 (6)

Articles

  • Articles
  • Issues
  • Popular Articles

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology: Neuroimmunology & Neuroinflammation
Online ISSN: 2332-7812

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise